Serum levels of the tumour‐associated trypsin inhibitor in patients with endometriosis

Adam N. Rosenthal, A Rosenthal
British journal of obstetrics and gynaecology · 1997 · vol. 104(8) , pp. 970–971 · doi:10.1111/j.1471-0528.1997.tb14366.x · PMID:9255095 · W1993484071
letter OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This study investigated serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

CA-125 Antigen Endometriosis Trypsin Inhibitors Biomarkers Biomarkers CA-125 Antigen Endometriosis Female Humans Sensitivity and Specificity Trypsin Inhibitors

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

References (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-10-07T06:10:45.703000+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:46.468712+00:00
unpaywall
last seen: 2026-10-07T06:26:57.292555+00:00
License: CC0 · commercial use OK